Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 240508, 8 pages
http://dx.doi.org/10.1155/2013/240508
Research Article

The Anticonvulsant Enaminone E139 Attenuates Paclitaxel-Induced Neuropathic Pain in Rodents

1Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Kuwait University, P.O. Box 24923, 13110 Safat, Kuwait
2Department of Pharmaceutical Sciences, School of Pharmacy, University of Saint Joseph, Hartford, CT 06103, USA

Received 22 October 2013; Accepted 20 November 2013

Academic Editors: S. Caccia and T. Nagai

Copyright © 2013 Dhandapani Thangamani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Wolf, D. Barton, L. Kottschade, A. Grothey, and C. Loprinzi, “Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies,” European Journal of Cancer, vol. 44, no. 11, pp. 1507–1515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Bhagra and R. D. Rao, “Chemotheraphy-induced neuropathy,” Current Oncology Reports, vol. 9, no. 4, pp. 290–299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. F. H. Hausheer, R. L. Schilsky, S. Bain, E. J. Berghorn, and F. Lieberman, “Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy,” Seminars in Oncology, vol. 33, no. 1, pp. 15–49, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. N. Reeves, S. R. Dakhil, J. A. Sloan et al., “Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1,” Cancer, vol. 118, no. 20, pp. 5171–5178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A.-L. Kautio, M. Haanpää, T. Saarto, and E. Kalso, “Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms,” Journal of Pain and Symptom Management, vol. 35, no. 1, pp. 31–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. D. Rao, J. C. Michalak, J. A. Sloan et al., “Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3),” Cancer, vol. 110, no. 9, pp. 2110–2118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. I. O. Edafiogho, C. N. Hinko, H. Chang et al., “Synthesis and anticonvulsant activity of enaminones,” Journal of Medicinal Chemistry, vol. 35, no. 15, pp. 2798–2805, 1992. View at Google Scholar · View at Scopus
  8. S. B. Kombian, I. O. Edafiogho, and K. V. V. Ananthalakshmi, “Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels,” British Journal of Pharmacology, vol. 145, no. 7, pp. 945–953, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Mulzac and K. R. Scott, “Profile of anticonvulsant activity and minimal toxicity of methyl 4-[(p- chlorophenyl)amino]-6-methyl-2-oxo-cyclohex-3-en-1-oate and some prototype antiepileptic drugs in mice and rats,” Epilepsia, vol. 34, no. 6, pp. 1141–1146, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Nishida, S. Kuchiiwa, S. Oiso et al., “Up-regulation of matrix metalloproteinase-3 in the dorsal root ganglion of rats with paclitaxel-induced neuropathy,” Cancer Science, vol. 99, no. 8, pp. 1618–1625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. S. Parvathy and W. Masocha, “Matrix metalloproteinase inhibitor COL-3 prevents the development of paclitaxel-induced hyperalgesia in mice,” Medical Principles and Practice, vol. 22, pp. 35–41, 2013. View at Publisher · View at Google Scholar
  12. K. V. Ananthalakshmi, I. O. Edafiogho, and S. B. Kombian, “Concentration-dependent effects of anticonvulsant enaminone methyl 4-(4′-bromophenyl)aminocyclohex-3-en-6-methyl-2-oxo-1-oate on neuronal excitability in vitro,” Neuroscience, vol. 141, no. 1, pp. 345–356, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. F. R. Nieto, J. M. Entrena, C. M. Cendán, E. D. Pozo, J. M. Vela, and J. M. Baeyens, “Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice,” Pain, vol. 137, no. 3, pp. 520–531, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. H. U. Zeilhofer, H. Möhler, and A. di Lio, “GABAergic analgesia: new insights from mutant mice and subtype-selective agonists,” Trends in Pharmacological Sciences, vol. 30, no. 8, pp. 397–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Zimmermann, “Ethical guidelines for investigations of experimental pain in conscious animals,” Pain, vol. 16, no. 2, pp. 109–110, 1983. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Hidaka, T. Shima, K. Nagira et al., “Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice,” European Journal of Pain, vol. 13, no. 1, pp. 22–27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Nirogi, V. Goura, D. Shanmuganathan, P. Jayarajan, and R. Abraham, “Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats,” Journal of Pharmacological and Toxicological Methods, vol. 66, pp. 8–13, 2012. View at Google Scholar
  18. J.-S. Walczak, V. Pichette, F. Leblond, K. Desbiens, and P. Beaulieu, “Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes,” Journal of Neuroscience Research, vol. 83, no. 7, pp. 1310–1322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Matsumoto, M. Inoue, A. Hald, W. Xie, and H. Ueda, “Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin,” Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 2, pp. 735–740, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. K. R. Scott, I. O. Edafiogho, E. L. Richardson et al., “Synthesis and anticonvulsant activity of enaminones. 2. Further structure-activity correlations,” Journal of Medicinal Chemistry, vol. 36, no. 14, pp. 1947–1955, 1993. View at Google Scholar · View at Scopus
  21. A. A. Argyriou, M. Koltzenburg, P. Polychronopoulos, S. Papapetropoulos, and H. P. Kalofonos, “Peripheral nerve damage associated with administration of taxanes in patients with cancer,” Critical Reviews in Oncology/Hematology, vol. 66, no. 3, pp. 218–228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Takeda, T. Ishida, R. Tsutsui et al., “Studies on somnolence in the daytime caused by drugs used for neuropathic pain,” Journal of Pharmacological Sciences, vol. 107, no. 3, pp. 246–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Dallocchio, C. Buffa, P. Mazzarello, and S. Chiroli, “Gabapentin versus amitriptyline in painful diabetic neuropathy: an open-label pilot study,” Journal of Pain and Symptom Management, vol. 20, no. 4, pp. 280–285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. S. O. Ogren, J. M. Cott, and H. Hall, “Sedative/anxiolytic effects of antidepressants in animals,” Acta Psychiatrica Scandinavica, vol. 290, pp. 277–288, 1981. View at Google Scholar · View at Scopus
  25. C. M. Morello, S. G. Leckband, C. P. Stoner, D. F. Moorhouse, and G. A. Sahagian, “Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain,” Archives of Internal Medicine, vol. 159, no. 16, pp. 1931–1937, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Gilron, J. M. Bailey, D. Tu, R. R. Holden, A. C. Jackson, and R. L. Houlden, “Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial,” The Lancet, vol. 374, no. 9697, pp. 1252–1261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Rowbotham, N. Harden, B. Stacey, P. Bernstein, and L. Magnus-Miller, “Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial,” Journal of the American Medical Association, vol. 280, no. 21, pp. 1837–1842, 1998. View at Google Scholar · View at Scopus
  28. N. Tsavaris, P. Kopterides, C. Kosmas et al., “Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study,” Pain Medicine, vol. 9, no. 8, pp. 1209–1216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Ardid and G. Guilbaud, “Antinociceptive effects of acute and “chronic” injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats,” Pain, vol. 49, no. 2, pp. 279–287, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Galeotti, C. Ghelardini, S. Capaccioli, A. Quattrone, A. Nicolin, and A. Bartolini, “Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel,” European Journal of Pharmacology, vol. 330, no. 1, pp. 15–25, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. F. S. Kilic, B. Sirmagul, E. Yildirim, S. Oner, and K. Erol, “Antinociceptive effects of gabapentin & its mechanism of action in experimental animal studies,” Indian Journal of Medical Research, vol. 135, pp. 630–635, 2012. View at Google Scholar
  32. K. R. Paudel, B. P. Das, G. P. Rauniar, H. Sangraula, S. Deo, and S. K. Bhattacharya, “Antinociceptive effect of amitriptyline in mice of acute pain models,” Indian Journal of Experimental Biology, vol. 45, no. 6, pp. 529–531, 2007. View at Google Scholar · View at Scopus
  33. D. Mahmood, M. Akhtar, D. Vohora, and R. Khanam, “Comparison of antinociceptive and antidiabetic effects of sertraline and amitriptyline on streptozotocin-induced diabetic rats,” Human and Experimental Toxicology, vol. 29, no. 10, pp. 881–886, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Peters, J. M. Jimenez-Andrade, M. A. Kuskowski, J. R. Ghilardi, and P. W. Mantyh, “An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat,” Brain Research, vol. 1168, no. 1, pp. 46–59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. R. C. Polomano and G. J. Bennett, “Chemotherapy-evoked painful peripheral neuropathy,” Pain Medicine, vol. 2, no. 1, pp. 8–14, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Xiao, A. Boroujerdi, G. J. Bennett, and Z. D. Luo, “Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit,” Neuroscience, vol. 144, no. 2, pp. 714–720, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Xiao, L. Naso, and G. J. Bennett, “Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies,” Pain Medicine, vol. 9, no. 5, pp. 505–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. K. V. V. Ananthalakshmi, I. O. Edafiogho, and S. B. Kombian, “Anticonvulsant enaminone E139 suppresses epileptiform activity in rat hippocampal slices,” Epilepsy Research, vol. 76, no. 2-3, pp. 85–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. B. Kombian, K. V. V. Ananthalakshmi, and I. O. Edafiogho, “Enaminones and norepinephrine employ convergent mechanisms to depress excitatory synaptic transmission in the rat nucleus accumbens in vitro,” European Journal of Neuroscience, vol. 24, no. 10, pp. 2781–2788, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. I. E. Dick, R. M. Brochu, Y. Purohit, G. J. Kaczorowski, W. J. Martin, and B. T. Priest, “Sodium channel blockade may contribute to the analgesic efficacy of antidepressants,” Journal of Pain, vol. 8, no. 4, pp. 315–324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. Y.-K. Hur, I.-S. Choi, J.-H. Cho et al., “Effects of carbamazepine and amitriptyline on tetrodotoxin-resistant Na+ channels in immature rat trigeminal ganglion neurons,” Archives of Pharmacal Research, vol. 31, no. 2, pp. 178–182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. J.-H. Song, S.-S. Ham, Y.-K. Shin, and C.-S. Lee, “Amitriptyline modulation of Na+ channels in rat dorsal root ganglion neurons,” European Journal of Pharmacology, vol. 401, no. 3, pp. 297–305, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Ghelardini, N. Galeotti, and A. Bartolini, “Antinociception induced by amitriptyline and imipramine is mediated by α(2A)-adrenoceptors,” Japanese Journal of Pharmacology, vol. 82, no. 2, pp. 130–137, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Esser and J. Sawynok, “Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain,” European Journal of Pharmacology, vol. 399, no. 2-3, pp. 131–139, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Ulugol, H. C. Karadag, M. Tamer, Z. Firat, A. Aslantas, and I. Dokmeci, “Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats,” Neuroscience Letters, vol. 328, no. 2, pp. 129–132, 2002. View at Publisher · View at Google Scholar · View at Scopus